Compare Immunovant Inc. Common Stock (IMVT) vs Super Micro Computer Inc (SMCI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Super Micro Computer Inc — how do they compare? Immunovant Inc. Common Stock trades at $30.47 (market cap $6.25B), while Super Micro Computer Inc trades at $41.86 (market cap $28.10B). The key difference: Super Micro Computer Inc is far larger — about 4.5× Immunovant Inc. Common Stock's market cap, and Super Micro Computer Inc is more actively traded (38,581,805 versus 1,755,411). Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 1 Days and Super Micro Computer Inc for 19 Days on average.
| IMVT | SMCI | |
|---|---|---|
Market Cap | $6.25B | $28.10B |
Volume | 1,755,411 | 38,581,805 |
Sector | Health | Technology |
52-Week High | $44.96 | $57.98 |
52-Week Low | $17.03 | $20.53 |
Typical Hold Time | 1 Days | 19 Days |
Enterprise Value | $5.35B | $33.56B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Super Micro Computer (SMCI) trades at $41.86, down 6.89% in the last session, but maintains strong fundamental momentum with three consecutive quarterly earnings beats and robust AI-driven revenue growth. The stock shows bullish technical signals with support at $40-42 levels, while valuation metrics remain attractive with P/E of 13.12 and P/S of 0.76. Recent news highlights AI server demand growth and successful NVIDIA Vera Rubin shipments, positioning SMCI as a key infrastructure player in the expanding AI market.
SMCI presents a compelling value opportunity with strong earnings momentum and AI infrastructure leadership, though investors face risks from competitive pressures and ongoing DOJ investigation. Analyst consensus targets $42.33 with 36% buy ratings, suggesting modest upside potential from current levels. The company's debt-to-asset ratio improvement from 33.93% to 29.12% indicates strengthening balance sheet management alongside projected revenue growth to $39.1B in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Super Micro Computer Inc
Super Micro Computer, Inc., commonly known as Supermicro, is a leading provider of high-performance and high-efficiency server technology and innovation. The company specializes in designing, manufacturing, and selling advanced server, storage, and networking solutions, primarily for data centers, cloud computing, artificial intelligence, and 5G/Edge computing markets. SMCI's modular architecture allows for the rapid delivery of customized and purpose-built solutions, making it a key player in the enterprise computing and specialized AI infrastructure space.
Read more on SMCI →
